JP2024533787A5 - - Google Patents

Info

Publication number
JP2024533787A5
JP2024533787A5 JP2024519528A JP2024519528A JP2024533787A5 JP 2024533787 A5 JP2024533787 A5 JP 2024533787A5 JP 2024519528 A JP2024519528 A JP 2024519528A JP 2024519528 A JP2024519528 A JP 2024519528A JP 2024533787 A5 JP2024533787 A5 JP 2024533787A5
Authority
JP
Japan
Prior art keywords
groups
substituted
unsubstituted
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024519528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533787A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/122205 external-priority patent/WO2023051628A1/zh
Publication of JP2024533787A publication Critical patent/JP2024533787A/ja
Publication of JP2024533787A5 publication Critical patent/JP2024533787A5/ja
Pending legal-status Critical Current

Links

JP2024519528A 2021-09-29 2022-09-28 ピリド六員環構造を有するsos1阻害剤 Pending JP2024533787A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202111155906 2021-09-29
CN202111155906.7 2021-09-29
CN202211141499.9 2022-09-20
CN202211141499 2022-09-20
PCT/CN2022/122205 WO2023051628A1 (zh) 2021-09-29 2022-09-28 一类具有吡啶并六元环结构的sos1抑制剂

Publications (2)

Publication Number Publication Date
JP2024533787A JP2024533787A (ja) 2024-09-12
JP2024533787A5 true JP2024533787A5 (enExample) 2025-10-01

Family

ID=85781333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024519528A Pending JP2024533787A (ja) 2021-09-29 2022-09-28 ピリド六員環構造を有するsos1阻害剤

Country Status (6)

Country Link
US (1) US20250042857A1 (enExample)
EP (1) EP4410790A4 (enExample)
JP (1) JP2024533787A (enExample)
CN (1) CN117999263A (enExample)
TW (1) TW202320766A (enExample)
WO (1) WO2023051628A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117062818B (zh) * 2021-03-05 2026-07-31 南京再明医药有限公司 Sos1抑制剂及其制备方法和应用
CN117024404A (zh) * 2022-05-10 2023-11-10 四川汇宇制药股份有限公司 苯并吡啶衍生物及其用途
WO2025188163A1 (ko) * 2024-03-07 2025-09-12 아이리드비엠에스 주식회사 Sos1 억제제 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265777A (enExample) * 1960-06-09
US3272824A (en) * 1962-12-06 1966-09-13 Norwich Pharma Co 4-amino-6, 7-di(lower) alkoxyquinolines
WO2003055866A1 (en) * 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
HUP0302440A3 (en) * 2003-07-31 2007-08-28 Sanofi Aventis Aminoquinoline derivatives, process for producing them and pharmaceutical compositions containing them
US20060074105A1 (en) * 2004-09-20 2006-04-06 Serenex, Inc. Substituted quinoline and quinazoline inhibitors of quinone reductase 2
CN101784533B (zh) * 2007-08-22 2013-08-21 艾博特股份有限两合公司 4-苄基氨基喹啉、含有它们的药物组合物和它们在治疗中的用途
US9187458B2 (en) * 2010-06-09 2015-11-17 Tianjin Hemay Bio-Tech Co., Ltd. Cyanoquinoline derivatives
BR122021012629B1 (pt) * 2013-02-01 2022-06-07 Wellstat Therapeutics Corporation Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos
CN108137547B (zh) * 2015-08-03 2021-11-12 百时美施贵宝公司 可用作TNFα调节剂的杂环化合物
PH12022551102A1 (en) 2019-11-08 2023-11-20 Revolution Medicines Inc Bicyclic heteroaryl compounds and uses thereof
WO2022156792A1 (en) * 2021-01-25 2022-07-28 Guangdong Newopp Biopharmaceuticals Co., Ltd. Heterocyclic compounds as sos1 inhibitors
CN117279914A (zh) * 2021-01-29 2023-12-22 南京再明医药有限公司 Sos1抑制剂及其制备方法和应用
CN115043842A (zh) * 2021-03-09 2022-09-13 苏州泽璟生物制药股份有限公司 胺基取代双环类抑制剂及其制备方法和应用

Similar Documents

Publication Publication Date Title
JP2022515198A5 (enExample)
JP2024543982A5 (enExample)
JP2022515197A5 (enExample)
JP2021512150A5 (enExample)
JP2013532652A5 (enExample)
JP2007528379A5 (enExample)
JP2013523614A5 (enExample)
RU2019106484A (ru) Гетероциклическое соединение
JPWO2020085493A5 (enExample)
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
RU2014115476A (ru) Производные пиразоло[4, 3-с]птридина в качестве ингибиторов киназ
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
JP2008501631A5 (enExample)
RU2000127020A (ru) Производные имидазопиридина, ингибирующие секрецию желудочной кислоты
MY189118A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives
JP2005535586A5 (enExample)
EA031030B1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
JP2013512903A5 (enExample)
CA2860951A1 (en) Imidazopyrrolidinone compounds
JP2010513447A5 (enExample)
JP2021535213A5 (enExample)
RU2018114518A (ru) Новые бициклические соединения в качестве двойных ингибиторов аутотаксина (atx)/карбоангидразы (ca)
IL205501A (en) Preparation of preparations for the treatment of arthritis
RU2014152790A (ru) Пирролопиразоновые ингибиторы танкиразы
CN111601797A (zh) 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用